January 2024

WASHINGTON, Jan. 23, 2024 /PRNewswire/ — Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application to evaluate VCA-894A for the treatment of a patient with Charcot-Marie-Tooth

Magazine made for you.

Featured:

No posts were found for provided query parameters.

Elsewhere: